The health benefits of medical marijuana have been widely debated at individual, society and global policy playgrounds. However, these arguments are mainly based on anecdotal evidence with little scientific underpinnings. Drawing on a single-case self-reported monitored wellbeing, this paper provides a preliminary feedback on a comparative narrative between pharmaceutical drugs and medical marijuana use in the treatment of migraine. Husserl’s phenomenological framework is used to address any form of imbalances in both perception and real-time experiences in use, while controlling for any bias that may have resulted from lop sided public information, perception and societal stigma. While some schools of thought project marijuana as a gateway drug to the infernal realm, this study provides a counter verdict based on real time practical experience from a well informed and educated user. Notwithstanding the immense benefits, an inappropriate, heavy and prolonged use of a high-THC strain marijuana among individuals undergoing brain development and/or with complicated underlying health conditions and family history of schizophrenia may have adverse effect on users. Therefore, the study’s inability to disentangle issues of causality and correlation has fragmented and complicated the findings. In effect, a legitimate concern is raised about having a well-informed, research-driven knowledge and awareness before using medical marijuana for any health purpose.

References are not ready for this file yet, please refer to reference from the PDF file

Keywords

Marijuana, Migraine, Phenomonology